Northern Trust’s Yarrow Bioscience YARW Stock Holding History

Northern Trust’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.4K	Buy	874 +412	+89%	+$13.4K	﹤0.01%	4339
2026 Q1	$13.8K	Hold	462	–	–	﹤0.01%	4359
2025 Q4	$13.4K	Hold	462	–	–	﹤0.01%	4420
2025 Q3	$7.74K	Hold	462	–	–	﹤0.01%	4412
2025 Q2	$38.1K	Sell	462 -17	-4%	-$1.1K	﹤0.01%	4276
2025 Q1	$37.9K	Hold	479	–	–	﹤0.01%	4270
2024 Q4	$80.3K	Sell	479 -267	-36%	-$34.9K	﹤0.01%	4198
2024 Q3	$70.1K	Sell	746 -7	-0.9%	-$663	﹤0.01%	4137
2024 Q2	$74.2K	Buy	753 +14	+2%	+$1.75K	﹤0.01%	4118
2024 Q1	$113K	Hold	739	–	–	﹤0.01%	4046
2023 Q4	$86.1K	Buy	+739	New	+$115K	﹤0.01%	4143
2023 Q1	–	Sell	-99	Closed	-$13.4K	–	4630
2022 Q4	$13.4K	Hold	99	–	–	﹤0.01%	4543
2022 Q3	$20K	Hold	99	–	–	﹤0.01%	4545
2022 Q2	$35K	Hold	99	–	–	﹤0.01%	4512
2022 Q1	$58K	Hold	99	–	–	﹤0.01%	4503
2021 Q4	$91K	Sell	99 -72	-42%	-$77.3K	﹤0.01%	4452
2021 Q3	$213K	Buy	171 +62	+57%	+$120K	﹤0.01%	4150
2021 Q2	$346K	Sell	109 -328	-75%	-$1.3M	﹤0.01%	3874
2021 Q1	$2.69M	Buy	437 +8	+2%	+$58K	﹤0.01%	3093
2020 Q4	$2.44M	Sell	429 -9	-2%	-$56.6K	﹤0.01%	3095
2020 Q3	$2.61M	Buy	438 +76	+21%	+$443K	﹤0.01%	2925
2020 Q2	$2.25M	Buy	362 +235	+185%	+$1.59M	﹤0.01%	2977
2020 Q1	$1.23M	Buy	127 +85	+202%	+$1.33M	﹤0.01%	3123
2019 Q4	$699K	Sell	42 -2	-5%	-$33.3K	﹤0.01%	3493
2019 Q3	$710K	Buy	44 +14	+47%	+$226K	﹤0.01%	3476
2019 Q2	$648K	Buy	30 +2	+7%	+$49.5K	﹤0.01%	3484
2019 Q1	$785K	Buy	28 +1	+4%	+$24K	﹤0.01%	3433
2018 Q4	$406K	Hold	27	–	–	﹤0.01%	3608
2018 Q3	$970K	Buy	27 +8	+42%	+$247K	﹤0.01%	3475
2018 Q2	$548K	Hold	19	–	–	﹤0.01%	3580
2018 Q1	$2.58M	Buy	+19	New	+$2.31M	﹤0.01%	2974

Other funds holding YARW

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $136M AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Northern Trust's YARW Position: Q2 2026 in Review

Northern Trust increased its Yarrow Bioscience (YARW) stake by 89% in Q2 2026, buying an estimated $13.4K and bringing the position to 874 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4339.

Northern Trust first reported a position in YARW in Q1 2018 and has held it in 31 quarters since. The position peaked at $2.69M in Q1 2021. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

Northern Trust held 874 shares of Yarrow Bioscience worth $28.4K as of Q2 2026.
Northern Trust bought 412 Yarrow Bioscience shares in Q2 2026, an estimated $13.4K.
Yarrow Bioscience made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4339 holding.
Northern Trust first reported a position in Yarrow Bioscience in Q1 2018 and has held it in 31 quarters since.
Northern Trust's Yarrow Bioscience position peaked at $2.69M in Q1 2021.
40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.